Healthcare -
Medical - Devices - NASDAQ - US
$ 196.82
-0.0812 %
$ 14.3 B
Market Cap
35.72
P/E
1. INTRINSIC VALUE
Balance Sheet
Align Technology, Inc.
| Current Assets | 2.49 B |
| Cash & Short-Term Investments | 1.04 B |
| Receivables | 1.03 B |
| Other Current Assets | 419 M |
| Non-Current Assets | 3.72 B |
| Long-Term Investments | 0 |
| PP&E | 1.38 B |
| Other Non-Current Assets | 2.34 B |
| Current Liabilities | 2.04 B |
| Accounts Payable | 109 M |
| Short-Term Debt | 31.1 M |
| Other Current Liabilities | 1.9 B |
| Non-Current Liabilities | 325 M |
| Long-Term Debt | 88.2 M |
| Other Non-Current Liabilities | 236 M |
EFFICIENCY
Earnings Waterfall
Align Technology, Inc.
| Revenue | 4 B |
| Cost Of Revenue | 1.2 B |
| Gross Profit | 2.8 B |
| Operating Expenses | 2.19 B |
| Operating Income | 608 M |
| Other Expenses | 186 M |
| Net Income | 421 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Align Technology, Inc.
| Net Income | 421 M |
| Depreciation & Amortization | 145 M |
| Capital Expenditures | -116 M |
| Stock-Based Compensation | 174 M |
| Change in Working Capital | -72.4 M |
| Others | 102 M |
| Free Cash Flow | 623 M |
Wall Street Analysts Price Targets
Align Technology, Inc.
Wall Street analysts predict an average 1-year price target for ALGN of $274 , with forecasts ranging from
a
low of
$225 to a high of $325 .
ALGN Lowest Price Target
Wall Street Target
225 USD
14.32%
ALGN Average Price Target
Wall Street Target
274 USD
39.21%
ALGN Highest Price Target
Wall Street Target
325 USD
65.13%
4. DIVIDEND
ANALYSIS
ALGN does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Align Technology, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
1.53 M USD 1
9-12 MONTHS
7. News
Britt Vitalone Joins Align Technology Board of Directors
TEMPE, Ariz. & SAN JOSE, Calif. & DALLAS--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Britt Vitalone, Executive Vice President and Chief Financial Officer (“CFO”), McKesson Corporation, to Ali.
businesswire.com
- 6 days ago
ALGN vs. SAUHY: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Align Technology (ALGN) or Straumann Holding AG (SAUHY). But which of these two stocks presents investors with the better value opportunity right now?
zacks.com
- 1 week ago
Align Technology to Announce Second Quarter 2025 Results on July 30, 2025
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2025 financial results on Wednesday, July 30, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and w.
businesswire.com
- 1 week ago
Align Technology Connects With Over 2,000 Doctors and Practice Staff at the 2025 Invisalign® Asia Pacific (APAC) Summit
BANGKOK--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights from the 2025 Invisalign® Asia Pacific (“APAC”) Summit held in Bangkok, Thailand, June 5 – 7, 2025. “With more than 3 million Invisalign smiles across Asia Pacific, we know.
businesswire.com
- 1 week ago
Reasons to Add Align Technology Stock to Your Portfolio Now
ALGN's Invisalign growth, iTero innovation and solid finances fuel optimism despite forex headwinds.
zacks.com
- 1 week ago
Align Technology Deserves A Rerate
Align Technology is transitioning from a device maker to a digital dentistry platform, leveraging AI software and recurring service revenues. The market undervalues ALGN, pricing it as a consumer product company despite its slow transition to higher-margin, recurring digital services. Expansion into restorative dentistry and new patient segments increases ALGN's addressable market and raises switching costs for dental clinics.
seekingalpha.com
- 2 weeks ago
Align Technology Launches Integrated Consumer and Professional Brand Campaign Focused on Invisalign® Treatment for Kids and Teens
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced integrated global professional and consumer campaigns to highlight the unique needs of growing patients and treatment options for meeting those needs and creating new smiles wi.
businesswire.com
- 3 weeks ago
Align Technology Awards Funding to Universities Worldwide for Advancing Orthodontic and Dental Research
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the award of twelve research grants to universities under the company's fifteenth Annual Research Award Program. “Align is pleased to grant the following research awards that.
businesswire.com
- 1 month ago
Align Technology (ALGN) Up 3.6% Since Last Earnings Report: Can It Continue?
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?
zacks.com
- 1 month ago
ALGN vs. MMSI: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Align Technology (ALGN) and Merit Medical (MMSI). But which of these two stocks is more attractive to value investors?
zacks.com
- 1 month ago
Align Technology Launches Professional Marketing Initiative Featuring Doctors at the Forefront of Digital Orthodontics and Their Stories in Transforming More Than 20M Smiles With Invisalign® Aligners
TEMPE, Ariz.--(BUSINESS WIRE)--New professional marketing initiative celebrates the role doctors play in digital orthodontics and provides a platform to inspire others.
businesswire.com
- 1 month ago
ALGN Stock Might Rise Following the NMPA Approval in China
Align Technology receives approval from the National Medical Products Administration in China for its Invisalign Palatal Expander System.
zacks.com
- 1 month ago
8. Profile
Summary
Align Technology, Inc. ALGN
COUNTRY
US
INDUSTRY
Medical - Devices
MARKET CAP
$ 14.3 B
Dividend Yield
0.00%
Description
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Contact
410 North Scottsdale Road, Tempe, AZ, 85281
https://www.aligntech.com
IPO
Date
Jan. 30, 2001
Employees
21200
Officers
Mr. Simon Beard
MD for EMEA Region & Executive Vice President
Mr. Stuart Hockridge
Executive Vice President of Global Human Resources
Mr. Zelko Relic
Executive Vice President & Chief Technology Officer
Mr. John F. Morici
Chief Financial Officer & Executive Vice President of Global Finance
Mr. Emory M. Wright
Executive Vice President of Direct Fabrication Platform & Operations
Ms. Shirley Stacy
Vice President of Corporate Communications & Investor Relations
Ms. Jennifer Olson-Wilk
Executive Vice President & Chief Customer Officer
Ms. Sreelakshmi Kolli
Executive Vice President & Chief Product and Digital Officer
Mr. Joseph M. Hogan
President, Chief Executive Officer & Director
Ms. Julie Ann Coletti J.D.
Executive Vice President and Chief Legal & Regulatory Officer